You are here: Industry Insights > Remdesivir

News List

Prices of remdesivir and favipiravir being monitored in India, says report europeanpharmaceuticalreview
August 10, 2020
Regulatory bodies in India are tracking the cost of remdesivir and favipiravir amid the COVID-19 pandemic but should consider price caps, a report has suggested.
Pfizer signs agreement with Gilead Sciences to manufacture remdesivir expresspharma
August 10, 2020
Pfizer will provide contract manufacturing services through its McPherson, Kansas plant.
Remdesivir and favipiravir price regulation required to safeguard patients’ interest in India: GlobalData expresspharma
August 04, 2020
Both drugs have seen a sharp decline in price since the availability of the first generic in India.
Health Canada authorises remdesivir as first Covid-19 treatment pharmaceutical-technology
July 30, 2020
Health Canada has granted conditional approval to Gilead Sciences’ remdesivir (Veklury) to treat patients with severe Covid-19 who have pneumonia and need oxygen support.
Researchers identify 21 existing drugs that block coronavirus in lab studies expresspharma
July 27, 2020
The study said that four of these compounds could work in combination with remdesivir, a current standard-of-care treatment for COVID-19.
DCGI nod for Jubilant’s generic remdesivir under brand name JUBI-R expresspharma
July 21, 2020
The company will distribute the drug in the Indian market through its distribution network and will be available by the first week of August 2020.
Remdesivir treatment gains popularity in India, black marketing and price cuts to continue: GlobalData expresspharma
July 21, 2020
According to figures compiled by the CDSCO, India will be producing 20,000 vials per day by the end of July.
We are monitoring sale, supply of medicines for COVID-19 treatment: Haryana FDA expresspharma
July 20, 2020
Haryana Medical Services Corporation (HMSC) has procured 400 vials of remdesivir and tocilizumab from Cipla to ensure availability of key drugs.
Mylan Secures Regulatory Approval for Remdesivir Lyophilized Powder for Injection in India americanpharmaceuticalreview
July 15, 2020
Mylan announced that the Drug Controller General of India (DCGI) has approved its remdesivir 100 mg/vial for restricted emergency use in India as part of the DCGI's accelerated approval process to address urgent, unmet needs amid the evolving ...
Inhaled formulation of remdesivir enters clinical trials europeanpharmaceuticalreview
July 14, 2020
Gilead reveals the novel inhaled formulation of remdesivir entered Phase I trials to establish if it could be used to treat mild to moderate COVID-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page